Package 51662-1481-1

{"route": ["INTRAVENOUS"], "spl_id": "11c3bf02-6616-9353-e063-6394a90af9cd", "openfda": {"unii": ["976728SY6Z"], "rxcui": ["849876", "1046406"], "spl_set_id": ["9d4d66f7-fa14-e832-e053-2a95a90a8b62"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BAG in 1 CARTON (51662-1481-1)  / 200 mL in 1 BAG", "package_ndc": "51662-1481-1", "marketing_start_date": "20200129"}], "brand_name": "NEXTERONE (AMIODARONE HCI)", "product_id": "51662-1481_11c3bf02-6616-9353-e063-6394a90af9cd", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antiarrhythmic [EPC]", "Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51662-1481", "generic_name": "NEXTERONE (AMIODARONE HCI)", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NEXTERONE (AMIODARONE HCI)", "active_ingredients": [{"name": "AMIODARONE HYDROCHLORIDE", "strength": "1.8 mg/mL"}], "application_number": "NDA022325", "marketing_category": "NDA", "marketing_start_date": "20200129", "listing_expiration_date": "20261231"}